Managing Myeloproliferative Neoplasms

Ruben A. Mesa is a consultant hematologist and Chair of the Division of Hematology and Medical Oncology at the Mayo Clinic, Scottsdale, AZ, USA. Claire Harrison is a consultant hematologist and Deputy Clinical Director in Cancer and Haematology at Guy's and St Thomas' NHS Foundation Trust, London, UK.

Preface; 1. Initial assessment of the undiagnosed patient who has an erythrocytosis, leucocytosis or thrombocytosis Mary Frances McMullin; 2. Practical approaches to molecular testing and diagnosis of mastocytosis, hypereosinophilia and MDS/MPN overlap syndromes Nicholas C. P. Cross, Dimitra Koumaki, Georgia Metzgeroth and Andreas Reiter; 3. Incidental splenomegaly: an approach to diagnosis Craig B. Reeder; 4. When to do a bone marrow biopsy and how to interpret it in the diagnosis of myeloproliferative neoplasm Hans Michael Kvasnicka; 5. Accurately assessing risk in your myeloproliferative neoplasm patient Francisco Cervantes and Arturo Pereira; 6. Incorporating symptomatic assessment in therapy choice for patients with myeloproliferative neoplasms Robyn M. Scherber, Holly L. Geyer and Ruben A. Mesa; 7. The newly diagnosed patient with essential thrombocythemia Guido Finazzi; 8. The newly diagnosed patient with polycythemia vera Alessandro M. Vannucchi and Paola Guglielmelli; 9. Longstanding polycythemia vera and essential thrombocythemia: monitoring and management goals Loula Papageorgiou and Claire Harrison; 10. Management of myelofibrosis: which patients are candidates for JAK inhibitors and how to manage patients on JAK inhibitor treatment Lorenzo Falchi and Srdan Verstovsek; 11. Hematopoietic cell transplantation for myelofibrosis: who and when? Veena Fauble and Vikas Gupta; 12. Systemic mast cell disease, diagnosis and management Deepti Radia; 13. Hypereosinophilia: an illustrated approach to diagnosis and management Jason Gotlib; 14. Myelodysplastic/myeloproliferative neoplasm overlap syndromes Aaron T. Gerds, Ramon V. Tiu and Mikkael A. Sekeres; 15. Atypical chronic myeloid leukemia and chronic neutrophilic leukemia Daniel A. Pollyea and Jeffrey T. Schowinsky; 16. Women and children with myeloproliferative neoplasms – special considerations Robert Schneidewend and Laura C. Michaelis; 17. Conception and pregnancy in myeloproliferative neoplasms Susan Robinson; 18. Managing acute vascular events in patients with myeloproliferative neoplasms David Garcia and Bethany T. Samuelson; 19. Challenging thrombotic scenarios in the myeloproliferative neoplasms: splanchnic vein thrombosis and others Brady L. Stein; 20. Familial myeloproliferative neoplasms – implications for patients and their families Sabina Swierczek and Josef Prchal; 21. Management of acute leukemia following myeloproliferative neoplasms Raoul Tibes; Index.